Evolve Your Success
JULY 25, 2023
Working in the field of spine medical sales is not just a job, but an extraordinary expedition driven by purpose, resilience, and ingenuity. In today’s episode, we dive into the world of spine medical sales with Taylor Laneville. He is a dynamic individual who transitioned from being an organic chemist to a highly esteemed medical sales consultant.
Fierce Pharma
JULY 26, 2023
As with Novo Nordisk’s popular offering for obesity, Wegovy, demand for Eli Lilly’s dual GIP/GLP-1 agonist Mounjaro appears to be outpacing supply once again. | The U.S. Food and Drug Administration has added a fourth dose of Lilly’s popular new diabetes med to its drug shortage database. The agency also expects supply issues with three other doses to persist longer than previously thought.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 28, 2023
A research paper has reported a practical framework suitable for a systematic step-by-step quality by design (QbD) approach for the pharmaceutical development of bilayer tablets. According to the authors, bilayer tablets have been considered one of the best options for the development of fixed-dose combination (FDC) formulations. By delivering active substances, they can avoid incompatibilities in solubility, stability, and therapeutic efficacy in a single dosage form.
PM360
JULY 26, 2023
As biosimilars make inroads across various disease states, oncology especially appears to have embraced the new breed of therapies. Biosimilar adoption, however, is not as simple as picking the lowest-cost option, according to one expert. Deciding which biosimilars to use requires a complex set of considerations for oncology clinics, notes Andre Harvin, PharmD, Executive Director of Pharmacy and Oncology Services at Cone Health.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharma Marketing Network
JULY 25, 2023
In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. However, with countless agencies available, it can be overwhelming to find the right one that aligns with your business objectives.
Fierce Pharma
JULY 28, 2023
On Monday during a quarterly earnings call, when Biogen CEO Chris Viehbacher was asked about the company’s potential to execute M&A, he randomly offered “we’ve got, I think, about $7.3 billion | Biogen has revealed a proposal to acquire Reata Pharmaceuticals for $7.3 billion. The Texas-based rare disease specialist brings newly approved Skyclarys, the first treatment for the neurologic disorder Friedreich’s ataxia with peak sales potential of $1.5 billion.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PM360
JULY 26, 2023
Today, the U.S. is facing an aging population, a mounting physician shortage, and increasing demands for a more equitable healthcare system. 1 According to the U.S. Surgeon General, burnout among healthcare workers has reached crisis levels. 2 It’s no wonder physicians across the country are limiting time with the industry and prioritizing their limited time with their patients.
Spotio
JULY 25, 2023
B2B sales has evolved over the years. Cold calling and direct mail are still useful for some sales processes, but the way in which we do business has changed a lot. More companies are investing in B2B sales teams — inside and outside — across a range of industries. The B2B buying process now has more decision-makers and touchpoints than it did just a few years ago.
Fierce Pharma
JULY 27, 2023
Eli Lilly continues to bolster the case for its dual GIP/GLP-1 agonist tirzepatide as a powerful weight loss agent. | Also known as Mounjaro in its approved type 2 diabetes indication, tirzepatide helped patients across two trials—Surmount-3 and Surmount-4—lose up to 26.6% of their body weight, Lilly said Thursday.
European Pharmaceutical Review
JULY 27, 2023
Cardiovascular diseases are the leading cause of death globally with over 18.5 million fatalities per year, corresponding to over 30 percent of all deaths. 1 Furthermore, there are 63.3 million people estimated to be living with heart failure , 2 and the five-year survival rate is similar to cancer and stroke. 3 Heart failure is characterised by fatigue and shortness of breath caused by a structural or functional cardiac abnormality that results in reduced cardiac output.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PM360
JULY 26, 2023
Digital fireworks were launched just hours after the July 4 th holiday in the U.S. with the official launch of Threads by Meta, a new platform that is a direct competitor of Twitter. It should be of no surprise to anyone that a flurry of Twitter competitors is now entering the marketplace. Ever since Elon Musk’s purchase of Twitter, a target has been on the back of one of the original and most polarizing social platforms.
Pharma Marketing Network
JULY 27, 2023
Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceutical companies, and medical device manufacturers alike. These partnerships not only improve patient outcomes but also foster mutual trust and collaboration. In this blog, we will explore five effective strategies to enhance your relationship-building efforts with HCPs and ultimately achieve better healthcare outcomes.
Fierce Pharma
JULY 27, 2023
To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” | To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” Approved by the FDA in January 2022, Vabysmo already crossed the one-billion-dollar sales mark in the first half of 2023.
European Pharmaceutical Review
JULY 27, 2023
A paper published in ACS Synthetic Biology has demonstrated a novel method for storing biological materials such as RNA and proteins via solid-state storage. This would be as a pill or a tablet, which can be dissolved in water for on-demand use. The innovation by researchers at California Polytechnic State University in the US could help overcome current limitations in the storage and handling of products derived from living cells.
PM360
JULY 26, 2023
Since passage of the Inflation Reduction Act (IRA) in August 2022, the focus of many industry analysts and pharmaceutical companies has been on two important first order concerns: identifying products to be negotiated by the Centers for Medicare & Medicaid Services (CMS) and assessing the direct impact on prices. Most companies have now completed the critical analyses associated with these direct effects.
Pharma Marketing Network
JULY 25, 2023
Ads Manager is a powerful platform that can help pharma companies reach their target audience and achieve their marketing goals. One of the ways to do this is to customize your audience. This means targeting your ads to people who are most likely to be interested in your products or services. Here are some tips for customizing your audience in Ads Manager for the pharma industry: Use demographics: You can target your ads based on demographics, such as age, gender, location, and interests.
Fierce Pharma
JULY 25, 2023
In reporting its first-quarter earnings, Biogen said it would halt the development of at least four investigational drugs to allow the company to focus on more lucrative opportunities. | In a sizable cost-cutting measure, Biogen will lay off 1,000 employees by 2025, it announced in presenting its second quarter earnings. With the company starting 2023 with 8,725 employees, that’s an 11.5% reduction of the workforce.
European Pharmaceutical Review
JULY 26, 2023
The European Commission (EC) has approved Jardiance ® (empagliflozin) for adults with chronic kidney disease (CKD). The oral, once-daily, highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor is the first type 2 diabetes medicine to include cardiovascular death risk reduction data for patients with type 2 diabetes and cardiovascular disease in its label in several countries.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PM360
JULY 26, 2023
Would it surprise you to know that the COVID-19 pandemic turned pharmacy priorities on its head, which could have the potential of morphing pharmacies into full-fledge healthcare centers over the long term? Pharmacy technicians (aka “techs”) and pharmacists alike were affected by COVID-19. Adding responsibilities of testing for COVID-19 and administering the vaccine in mass volumes when it became available, pharmacists and techs had to shuffle workload and priorities in a way that supported this
Pharma Marketing Network
JULY 26, 2023
The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. One of the FDA’s enforcement mechanisms is the issuance of marketing violation letters to pharmaceutical companies found in violation of advertising and promotion regulations.
Fierce Pharma
JULY 25, 2023
Patients with the eyelid disease Demodex blepharitis can now see a cure in Tarsus Pharmaceuticals’ Xdemvy, the first FDA-approved treatment for an ailment that affects some 25 million Americans.
European Pharmaceutical Review
JULY 25, 2023
Axatilimab, an anti-CSF-1R antibody to treat chronic graft-versus-host disease (GVHD) has, in a pivotal Phase II trial, demonstrated overall response rates (ORR) of 74 percent, 67 percent and 50 percent, within the first six months of treatment. “[It] is the first investigational chronic GVHD treatment to target inflammation and fibrosis through the inhibition of disease associated macrophages,” stated Michael A Metzger, Chief Executive Officer of Syndax Pharmaceuticals.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
JULY 26, 2023
More than 600 rural U.S. hospitals — which is more than 30% of the country’s rural hospitals — are at risk of closing due to their financial instability, according to a new report. The report argued that the dire financial situation among the nation’s rural hospitals stems from two main issues: low financial reserves and inadequate payments from private health plans.
Pharma Marketing Network
JULY 25, 2023
Google Ads is a great way to reach a wider audience for your pharma business. However, if you want to get the most out of your Google Ads campaigns, you need to optimize them for SEO. Here are some tips on how to increase SEO on Google Ads for the pharma industry: Use relevant keywords: When you’re creating your Google Ads campaigns, make sure to use relevant keywords.
Fierce Pharma
JULY 26, 2023
With a European approval for chronic kidney disease nod in hand, Boeringer Ingelheim and Eli Lilly's Jardiance is looking to catch up to AstraZeneca's Farxiga in this use and continue growing its r | After recent label expansions in the U.S. and Europe paid off with a sizable sales increase for Jardiance, the drug has added a third use to its European label.
European Pharmaceutical Review
JULY 27, 2023
ENHERTU ® (trastuzumab deruxtecan) has demonstrated clinically meaningful progression-free survival (PFS) and overall survival (OS) in topline results from the primary analysis of the ongoing DESTINY-PanTumor02 Phase II trial. The data was for previously treated patients across multiple HER2 expressing advanced solid tumours, two secondary endpoints.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
PharmExec
JULY 26, 2023
As we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry.
Pharma Marketing Network
JULY 25, 2023
Traditionally, pharmaceutical companies have relied on demographics to target their marketing efforts. This means that they have focused on reaching consumers based on factors such as age, gender, income, and location. While demographics can be a useful starting point, they are not always enough to create effective marketing campaigns. This is because consumers are not just defined by their demographics.
Fierce Pharma
JULY 25, 2023
Just as the calls for a business separation grow louder at Bayer, the company’s weedkiller performance is bolstering the argument with dramatically declining sales. | Just as the calls for a business separation grow louder at Bayer, the company’s weedkiller performance is bolstering the argument with dramatically declining sales.
European Pharmaceutical Review
JULY 24, 2023
Roche and Alnylam Pharmaceuticals have agreed to jointly develop and commercialise zilebesiran, an RNAi therapeutic as a treatment for hypertension. Under the partnership, Alnylam will receive an upfront payment of $310 million from Roche and is eligible to receive development, regulatory and commercial milestones. Zilebesiran is an investigational, subcutaneously administered RNAi therapeutic targeting angiotensinogen (AGT).
Expert insights. Personalized for you.
52 
Let's personalize your content